Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21064484 | 0.88 | ALOX15 (0.35) | LMNAHSD17B10ALOX15CA1CA2 | |
| SCHEMBL16300071 | 0.81 | LMNA (0.35) | LMNAHSD17B10ALOX15 | |
| SCHEMBL10093711 | 0.80 | — | — | |
| SCHEMBL19920790 | 0.79 | LMNA (0.30) | LMNAHSD17B10 | |
| SCHEMBL25710706 | 0.79 | LMNA (0.30) | LMNAHSD17B10 | |
| SCHEMBL19920565 | 0.79 | LMNA (0.30) | LMNAHSD17B10 | |
| SCHEMBL26790374 | 0.78 | LMNA (0.30) | LMNAALOX15BLMPMP22MAPT | |
| SCHEMBL10069149 | 0.76 | — | — | |
| SCHEMBL30605467 | 0.75 | FDPS (0.39) | LMNAHSD17B10CA1CA2 | |
| SCHEMBL284018 | 0.74 | TSHR (0.40) | TSHRTDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3845394-A1 | PLANOGRAPHIC PRINTING ORIGINAL PLATE, METHOD FOR PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING METHOD AND CURABLE COMPOSITION | FUJIFILM Corporation (JP) | 2021-07-07 | — | — | EP | disclosed |
| US-9272164-B2 | Method of achieving improved hair feel | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-01 | — | — | US | disclosed |
| US-20130089586-A1 | Method of Achieving Improved Hair Feel | THE PROCTER & GAMBLE COMPANY (US) | 2013-04-11 | — | — | US | disclosed |
| EP-2236557-A1 | HYDROPHILIC COMPOSITION HAVING MILDEWPROOFING EFFECT AND HYDROPHILIC MEMBER | FUJIFILM Corporation (JP) | 2010-10-06 | — | — | EP | disclosed |
| CN-1187404-C | Flexible syndiotactic polypropylene compositions and molded object | MITSUI CHEMICALS INC (JP) | 2005-02-02 | — | — | CN | disclosed |
| CN-1313880-A | Soft syndiotactic polypropylene compositions and shaped products | MITSUI CHEMICALS INC (JP) | 2001-09-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130089586-A1 | Method of Achieving Improved Hair Feel | POLR1C, PMP22, SUCLG1 | LMNA 1314/4885HSD17B10 296/4885ALOX15 3204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.